Synergistic Reversal of Type 1 Diabetes in NOD Mice With Anti-CD3 and Interleukin-1 Blockade: Evidence of Improved Immune Regulation

Inflammatory cytokines are involved in autoimmune diabetes: among the most prominent is interleukin (IL)-1β. We postulated that blockade of IL-1β would modulate the effects of anti-CD3 monoclonal antibody (mAb) in treating diabetes in NOD mice. To test this, we treated hyperglycemic NOD mice with F(...

Descripción completa

Detalles Bibliográficos
Autores principales: Ablamunits, Vitaly, Henegariu, Octavian, Hansen, Jakob Bondo, Opare-Addo, Lynn, Preston-Hurlburt, Paula, Santamaria, Pere, Mandrup-Poulsen, Thomas, Herold, Kevan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Immunology and Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237664/
https://www.ncbi.nlm.nih.gov/pubmed/22043003
http://dx.doi.org/10.2337/db11-1033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237664/
https://www.ncbi.nlm.nih.gov/pubmed/22043003
http://dx.doi.org/10.2337/db11-1033

Ejemplares similares